Astrositoma Dokter Terbaik di Israel - TOP-7 dokter

Lebih dari 900 prosedur telah dilakukan – Dr. Blumental adalah ahli neuro-onkologi yang sangat berpengalaman dan direktur Layanan Neuro-onkologi di Sourasky Medical Center.

• 29 tahun pengalaman di bidang onkologi
• Direktur Layanan Neuro-onkologi di Huntsman Cancer Institute
• Menempuh pelatihan di Memorial Sloan-Kettering Cancer Center
• Spesialisasi dalam perawatan onkologi dengan tingkat keberhasilan tinggi

Dr. Felix Bokstein memimpin Klinik Neuroonkologi di Ichilov – salah satu rumah sakit terbesar dan tercanggih di Israel, yang berfokus khusus pada tumor otak.

• Fokus utamanya adalah menangani tumor otak dan sumsum tulang belakang yang kompleks.
• Sebagai Kepala Klinik, ia mengawasi unit neuro-onkologi khusus.
• Pengalamannya mencakup penanganan glioma, astrositoma, dan keganasan SSP lainnya.
• Mengintegrasikan kemoterapi, terapi target, dan opsi uji klinis ke dalam rencana pengobatan.

Profesor Zvi Ram mengepalai European Association of Neurosurgical Societies (EANS) – sebuah peran tingkat tinggi yang menonjolkan kepemimpinannya di bidang ini.

• Berspesialisasi dalam bedah invasif minimal dan teknik pemetaan otak
• Menjadi ahli dalam operasi bedah saraf, termasuk stimulasi otak dalam (DBS)
• Melakukan bedah saraf dengan panduan gambar untuk tumor otak, menempuh pelatihan di Yunani dan Swiss
• Memimpin penelitian tentang terapi berbasis gen untuk kanker otak
• Menerima penghargaan Borenstein Award dari Brain & Behavior Research Foundation

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.